bioMérieux S.A. (BIM.PA)

99,50 +0,50 (+0,51%) A partir del 04:05PM CEST. Mercado abierto.

bioMérieux S.A.

376 Chemin De l’Orme
Marcy l'Étoile 69280
France
33 4 78 87 20 00
https://www.biomerieux.com

Sector(es): Healthcare
Sector: Diagnostics & Research
Empleados a tiempo completo: 13.409

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Pierre Boulud	Chief Executive Officer	1,35M	N/A	1971
Mr. Guillaume Bouhours	Executive VP of Purchasing and Information Systems & CFO	N/A	N/A	1976
Sylvain Morgeau	Investor Relations	N/A	N/A	N/A
Ms. Audrey Dauvet	Executive Vice President of Legal, Corporate Integrity & Public Affairs	N/A	N/A	1974
Ms. Valerie Leylde	Executive Vice President of Human Resources, Communications & CSR	N/A	N/A	N/A
Mr. Pierre Charbonnier	Executive Vice President of Global Quality, Manufacturing & Supply Chain	N/A	N/A	N/A
Mr. Yasha Mitrotti	Executive Vice President of Industrial Applications	N/A	N/A	N/A
Mr. Frederic Beseme	Head of CSR	21,99k	N/A	1956
Jennifer Zinn	Executive Vice President of Clinical Operations	N/A	N/A	N/A
Charles K. Cooper	Executive VP & Chief Medical Officer	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Gobierno corporativo

El ISS Governance QualityScore de bioMérieux S.A., a día 1 de abril de 2024, es 9. Las puntuaciones base son Auditoría: 5; Tablero: 8; Derechos de los accionistas: 8; Compensación: 10.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.